Category: Covid-19 Vaccine

Page 48«..1020..47484950..6070..»

Older adults now able to receive additional dose of updated COVID-19 vaccine – Villages-News

March 5, 2024

The Centers for Disease Control and Prevention is now recommending that those 65 years and older should receive an additional updated 2023-2024 COVID-19 vaccine dose.

The recommendation acknowledges the increased risk of severe disease from COVID-19 in older adults, along with the currently available data on vaccine effectiveness.

PreviousCDC recommendationsensured that people who are immunocompromised are already eligible for additional doses of the COVID-19 vaccine.

Data continues to show the importance of vaccination to protect those most at risk for severe outcomes of COVID-19. An additional dose of the updated COVID-19 vaccine may restore protection that has waned since a fall vaccine dose, providing increased protection to adults ages 65 years and older.

Adults 65 years and older are disproportionately impacted by COVID-19, with more than half of COVID-19 hospitalizations during October 2023 to December 2023 occurring in this age group.

CDC and ACIP will continue to monitor COVID-19 vaccine safety and effectiveness. CDC continues to recommend that everyonestay up to date on their COVID-19 vaccines, especiallypeople with weakened immune systems.

Read this article:

Older adults now able to receive additional dose of updated COVID-19 vaccine - Villages-News

Older Adults Now Able to Receive Additional Dose of Updated COVID-19 Vaccine | CDC Online Newsroom | CDC – CDC

March 1, 2024

Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices (ACIP) recommendation for adults ages 65 years and older to receive an additional updated 2023-2024 COVID-19 vaccine dose.The recommendation acknowledges the increased risk of severe disease from COVID-19 in older adults, along with the currently available data on vaccine effectiveness.

Previous CDC recommendations ensured that people who are immunocompromised are already eligible for additional doses of the COVID-19 vaccine.

Data continues to show the importance of vaccination to protect those most at risk for severe outcomes of COVID-19. An additional dose of the updated COVID-19 vaccine may restore protection that has waned since a fall vaccine dose, providing increased protection to adults ages 65 years and older.

Adults 65 years and older are disproportionately impacted by COVID-19, with more than half of COVID-19 hospitalizations during October 2023 to December 2023 occurring in this age group.

CDC and ACIP will continue to monitor COVID-19 vaccine safety and effectiveness. CDC continues to recommend that everyonestay up to date on their COVID-19 vaccines, especiallypeople with weakened immune systems.

The following is attributable to Dr. Mandy Cohen:

Todays recommendation allows older adults to receive an additional dose of this seasons COVID-19 vaccine to provide added protection, said Mandy Cohen, M.D., M.P.H. Most COVID-19 deaths and hospitalizations last year were among people 65 years and older. An additional vaccine dose can provide added protection that may have decreased over time for those at highest risk.

Read more:

Older Adults Now Able to Receive Additional Dose of Updated COVID-19 Vaccine | CDC Online Newsroom | CDC - CDC

Kent COVID-19 Vaccination Clinic open until the end of March – Public Health Insider

March 1, 2024

Leer en espaol

Public Healths Kent COVID-19 Vaccination Clinic will closeafter Saturday, 3/30/24due to a decrease in federal funding. Snoqualmie Valley Hospital will also close its COVID-19 drive-through vaccination site on March 30. Now is a good time to get up to date on COVID-19 vaccination while these sites are open!

Its especially important for older adults to get the latest COVID-19 vaccine to protect against the strains of COVID people are catching now. As of 2/28/24, the CDC now recommends that people 65 and older get an additional dose of the updated (2023-24) COVID-19 vaccine.

Through the end of March, COVID-19 vaccinations are available at our Kent site:

Hours:Tuesday through Saturday, 9:30 am to 6:00 pm (closed 12:30 pm to 1:30 pm for lunch).

Park and Vax:If you need to be vaccinated in your car, call206-477-6950to schedule a Park and Vax appointment.

Address:Kent Public Health Center, 25742 104th Ave SE, Kent, WA 98030

Drops-ins are welcome. However, please make an appointment if possible:

You can get COVID-19 vaccinations and other vaccinations at community health centers, most pharmacies, and other healthcare providers. Find a vaccination location atvaccines.gov. These locations will continue after the end of March.

If you are looking for vaccination for children under 3 years,contact your childs pediatrician or a Childhood Vaccine Program (CVP) provider. Find a CVP provider on thismap.

Public Health offers in-home COVID-19 vaccination through at least June of this year at no cost. The program is for anyone who has difficulty leaving home due to a disability, health condition, injury, etc. Call our In-Home COVID-19 Vaccine Program at 206-848-0243 or email vaccineinfo@kingcounty.gov

We are enormously proud and grateful to our staff who have made it possible to vaccinate over 3,340 people since October. Thank you for helping to protect the health of King County!

For more information: kingcounty.gov/vaccine

Originally published on February 29, 2024.

View original post here:

Kent COVID-19 Vaccination Clinic open until the end of March - Public Health Insider

Science Update: Timing of COVID-19 vaccination drives menstrual cycle changes, NIH-funded study suggests – National Institute of Child Health and…

March 1, 2024

Receiving a COVID-19 vaccine during the first half of the menstrual cycle is linked to a small, temporary increase in cycle length, suggests a study funded by the National Institutes of Health. Analysis of data from nearly 20,000 people indicates that those vaccinated during the follicular phasethe part of the menstrual cycle leading up to ovulationare more likely to experience a cycle length increase than those vaccinated during the luteal phase, which begins after ovulation. The findings provide additional information about what to expect after COVID-19 vaccination, potentially helping to reduce vaccine hesitancy.

The work was led by Alison Edelman, M.D., M.P.H., of the Oregon Health & Science University and funded by NIHs Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and Office of Research on Womens Health. The findings are published in Obstetrics & Gynecology.

NICHD-supported research has established that COVID-19 vaccination is associated with a small, temporary increase in menstrual cycle length. Although most of these changes are within the normal range of variation, they may be alarming to those who experience them and could contribute to fears and anxiety around vaccination. Researchers are working to better understand the mechanisms by which COVID-19 vaccination may affect menstrual cycles.

Hormones act as signals to control menstrual cycle timing. Stressors such as an immune response can disrupt this tightly controlled signaling and lead to longer cycle lengths, particularly when the stress occurs during the follicular phase. Scientists therefore surmised that the timing of COVID-19 vaccination may be an important factor in the observed changes in cycle length.

The researchers analyzed data from 19,497 users of the Natural Cycles menstrual tracking app who had regular cycles before vaccination. The apps ovulation prediction algorithm allowed the scientists to distinguish between those who received a COVID-19 vaccine during the follicular phase of their cycle and those who received it during the luteal phase. They compared data from these groups to data from a group of app users who did not receive a COVID-19 vaccine.

On average, individuals who received a COVID-19 vaccine during the follicular phase experienced a one-day increase in the length of the cycle in which they were vaccinated. Changes typically resolved in the cycle after vaccination. Those who were vaccinated during the luteal phase or did not receive a COVID-19 vaccine experienced no change in cycle length.

The results indicate that the timing of COVID-19 vaccination drives the temporary increases in menstrual cycle length seen after vaccination, supporting the theory that vaccine-induced immune responses during the follicular phase may affect the hormonal signaling that controls cycle length. Its helpful for us to understand why a change may happen, and these findings provide some insight into that, said Dr. Edelman. We hope this work helps validate the publics experiences and ease fears and anxiety around vaccination.

The authors call for additional work to establish whether their observations apply to people who experience irregularities in their cycle. They also hope to better understand how vaccination timing may affect other aspects of the menstrual cycle such as flow.

Edelman A et al. Timing of COVID-19 vaccination and effects on menstrual cycle changes. Obstetrics & Gynecology DOI: 10.1097/AOG.0000000000005550 (2024)

More:

Science Update: Timing of COVID-19 vaccination drives menstrual cycle changes, NIH-funded study suggests - National Institute of Child Health and...

Louisiana’s health leadership changes open the door to medical misinformation Louisiana Illuminator – Louisana Illuminator

March 1, 2024

The anti-vaccination crowd celebrated this weeks news that Dr. Joe Kanter is stepping down as Louisianas chief medical officer. In his role with the state health department, Kanter led efforts to slow the spread of COVID-19 and encouraged the public to get the vaccine.

He did so out of a sense of duty and without flinching as critics increasingly questioned the proven science behind the policy he enforced.

His departure was reason to rejoice for the science deniers who have been re-energized since Republican Gov. Jeff Landry won his election on promises he would stand firm against any public health measure he deems an encroachment on freedom. As attorney general, he took every opportunity to challenge and lash out at then-Gov. John Bel Edwards for the Democrats executive orders to contain the spread of COVID-19.

Louisiana officials continued emphasis on vaccinations has been in question since Landrys election and his subsequent appointment of Dr. Ralph Abraham as state health department secretary. Kanter announced his exit less than two months into Abrahams tenure.

Abraham, a former congressman and 2019 governor candidate, was a practicing physician before he took his seat in the U.S. House and a veterinarian before that.

Early in the pandemic, Abraham supported the off-label use of drugs to treat COVID that lacked federal regulatory approval, indicating he was open to alternatives at a time when researchers still hadnt developed a vaccine.

There are times when certain drugs need to be tried that have worked even anecdotally, give the patient the option, let them and their doctor make an informed decision, Abraham told the Louisiana Radio Network in March 2020.

With regards to vaccines, there was an encouraging message from Abrahams agency last week when it announced two cases of measles had been diagnosed in the New Orleans area. The Louisiana Department of Health reported that the infected individuals had not been immunized, and officials encouraged the public to obtain the MMR vaccine, calling it highly effective and safe.

GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX

SUBSCRIBE

It remains to be seen if there will be a similar message regarding COVID-19 vaccines, as the virus continues to mutate into new strands and pose a public health threat. The Centers for Disease Control and Prevention is recommending a booster for older adults.

If Rep. Raymond Crews, R-Bossier City, had his way, Abraham and the health department would disregard the CDCs recommendation.

Crews said as much Tuesday during a meeting of the House Health and Welfare Committee where Abraham made his first legislative appearance since taking his new job. The state representative took a shot at how the health department under the Edwards administration followed the federal health agencys advice.

It seemed to me the CDC told us what to do, and we went with it, Crews told Abraham.

Crews also shared his dismay during the pandemic over health care professionals not being familiar with experts, whose names he shared in the committee meeting. They are:

I mention those names, and they act like theyve never heard of them, Crews said.

That might be because the doctors hes confronted are reputable and embrace data-driven, peer-reviewed science over dangerous quackery. Or those doctors might just have had the same response Abraham did after Crews comments: silence with a polite smile.

For the sake of public health, lets hope our new health secretary doesnt become an echo chamber for such medical misinformation, even when it supports the political agenda of his boss.

View original post here:

Louisiana's health leadership changes open the door to medical misinformation Louisiana Illuminator - Louisana Illuminator

Is that CDC phone call asking about COVID and other vaccines legit? Check your caller ID – NorthJersey.com

March 1, 2024

northjersey.com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use.

Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on northjersey.com

Originally posted here:

Is that CDC phone call asking about COVID and other vaccines legit? Check your caller ID - NorthJersey.com

CDC: Adults 65 and older urged to get additional COVID-19 vaccine – NewsCenterMaine.com WCSH-WLBZ

March 1, 2024

The U.S. Centers for Disease Control and Prevention says an extra dose can boost protection that may have diminished, especially for people who are at high risk.

Author: newscentermaine.com

Published: 7:05 PM EST February 29, 2024

Updated: 7:05 PM EST February 29, 2024

Read more:

CDC: Adults 65 and older urged to get additional COVID-19 vaccine - NewsCenterMaine.com WCSH-WLBZ

Insights on Vaccination’s Role in Protecting Hypertensive Patients from COVID-19 – Contagionlive.com

March 1, 2024

The role of COVID-19 vaccination in protecting hypertensive patients from severe outcomes advocates prioritization alongside blood pressure management. Research indicates that patients with poorly controlled hypertension face a higher risk of severe COVID-19 outcomes, such as increased hospitalizations, intensive care unit admissions, and ventilator support requirements. This situation underscores the importance of vaccination and maintaining up-to-date vaccinations for individuals with poorly controlled hypertension to prevent infection and its severe consequences.

Robert Walker MD, senior vice president and chief medical officer at Novavax, assesses the effectiveness of COVID-19 vaccines in preventing serious illness in individuals with high blood pressure and determines their impact on reducing the risk of adverse cardiac events, including myocardial infarctions and strokes.

120 million people have hypertension, and only a quarter of them, said Walker. You know, there are other cardiovascular diseases and other comorbidities that put people at increased risk of all these things that we've been talking about, not just hypertension. So, the public health effect, the impact would be huge just based on the sheer numbers of people that we're talking about here.

The effectiveness of COVID-19 vaccines was evaluated through pivotal efficacy trials leading to their licensure and further supported by 2 large database studies conducted aimed at understanding the vaccines' role in preventing major adverse cardiac events among individuals with high blood pressure.

We know that COVID vaccines are highly effective at preventing infection, Walker states. We know that from many studies that have been done as pivotal efficacy trials that lead to the licensure of these vaccines. We also know from 2 very large database studies, 1 conducted in the US, and 1 conducted in Korea, that COVID-19 vaccines can prevent major adverse cardiac events. And by major adverse cardiac events, we're talking about acute myocardial infarctions and strokes. And their relative risk reductions have been shown in these studies range from 20 to 40%.

Currently, in the United States, there are primarily 2 categories of vaccines: mRNA vaccines and protein-based vaccines, NovaVax, specializes in protein-based vaccines. The goal of both vaccine types is to elicit an immune response against the SARS-CoV-2 virus, thereby safeguarding individuals from infection, illness, and the severe outcomes that can arise, particularly in adults.

I think it's important to have those conversations to understand the 2 different types of vaccines that are available, and also make sure that you're staying up to date, you want to make sure that the vaccine you receive is intended to protect against the viruses that are the strains of viruses that are currently circulating in the community. So, the vaccine that we received a year ago, is probably not going to be the best protection for what circulating now. General good hygiene and good advice is to stay in touch with your physician, and make sure your underlying illnesses, if you have them are being well managed and appropriately controlled. All those efforts together, I think will do their part to keep people healthy.

All in all, insights from Novavax and Dr. Robert Walker emphasize vaccines' role in mitigating severe health outcomes. Ensuring vaccinations are current and managing underlying health conditions are paramount in protecting this vulnerable group. Through collective adherence to these strategies, we can significantly reduce COVID-19 impact on those with hypertension and the wider community.

Read this article:

Insights on Vaccination's Role in Protecting Hypertensive Patients from COVID-19 - Contagionlive.com

Wenstrup investigates FDAs rushed approval of COVID-19 shot – The Highland County Press

March 1, 2024

WASHINGTON, D.C. Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) is investigating possible undue interference on the accelerated approval of Pfizers COVID-19 vaccine by the U.S. Food and Drug Administration (FDA).

During the Select Subcommittees hearing titled Assessing Americas Vaccine Safety Systems, Part 1, FDA Director Dr. Peter Marks testified that the FDAs approval of the COVID-19 vaccine may have been rushed in order to meet arbitrary mandate policies set forth by the Biden Administration.

Previous documents uncovered by the Select Subcommittee revealed that scientists warned Dr. Marks and other FDA officials on numerous occasions about the dangers of rushing the COVID-19 vaccine approval process.

The FDA seemingly disregarded the warnings, dismissed the scientists who brought forward the concerns, and went forward with the accelerated approval process. The day after approval, the Biden Administration announced its first COVID-19 vaccine mandate.

Chairman Wenstrup is reiterating requests for transcribed interviews with Dr. Peter Marks and former FDA Commissioner Dr. Janet Woodcock.

The chairman is also asking current FDA Commissioner Dr. Robert Califf to provide documents and information related to the COVID-19 vaccine approval process.

Dr. Peter Markss Feb. 15, 2024 testimony:

Notably, on August 9, 2021, U.S. Defense Secretary Lloyd Austin stated that he would, make the COVID-19 vaccines mandatory no later than mid-September, or immediately upon the U.S. Food and Drug Administration (FDA) licensure, whichever comes first.

This assertion could have increased pressure on Biden Administration officials to expedite approval of the COVID-19 vaccine. Less than a month later, on August 23, the FDA approved the COVID-19 vaccine for public use.

One day after the FDAs approval, Secretary Austin issued a memorandum mandating the COVID-19 vaccine for all U.S. military service members.

* * *

Publisher's note: A free press is critical to having well-informed voters and citizens. While some news organizations opt for paid websites or costly paywalls, The Highland County Press has maintained a free newspaper and website for the last 25 years for our community. If you would like to contribute to this service, it would be greatly appreciated. Donations may be made to: The Highland County Press, P.O. Box 849, Hillsboro, Ohio 45133. Please include "for website" on the memo line.

See the original post:

Wenstrup investigates FDAs rushed approval of COVID-19 shot - The Highland County Press

CDC vaccine advisers say older adults should get 2nd coronavirus shot – The Washington Post

March 1, 2024

The Centers for Disease Control and Prevention recommended Wednesday that people 65 and older get a second dose of a coronavirus vaccine made available in the fall because they are at higher risk for severe disease from the virus.

Most covid-19 deaths and hospitalizations last year were among people 65 years and older. An additional vaccine dose can provide added protection that may have decreased over time for those at highest risk, CDC Director Mandy Cohen said in a statement after endorsing the recommendation from the agencys vaccine advisory panel.

The 11-1 vote, with one abstention, by the Advisory Committee on Immunization Practices appeared to take some members by surprise.

A subgroup of advisers had suggested softer language that would have said older adults may get a second dose instead of should. That language, members said, would have given clinicians more flexibility and also takes into account growing vaccine hesitancy four years into the pandemic.

But Camille Kotton, clinical director for transplant and immunocompromised host infectious diseases at Massachusetts General Hospital in Boston, pushed for the stronger language so clinicians can make clearer recommendations to patients. Too many Americans are still unaware they should be getting a coronavirus vaccine, she said. Using the word may is too soft, especially for the most vulnerable, she said.

Demetre Daskalakis, who directs the CDC center overseeing respiratory infectious-disease threats, warned the panel that more absolute statements around vaccines will create a chilling effect for folks who have not been vaccinated.

A CDC recommendation means that those who are eligible for a second shot will have that additional dose covered by insurance. Eligible consumers should be able to get the additional dose within a day or two from pharmacies or health-care providers stocking the vaccines. There are no supply shortages, CDC officials said.

The recommendation applies only to those 65 and older. The additional dose should be given at least four months after a previous dose for healthy older adults, or at least three months after a coronavirus infection. Its unclear whether those getting a second shot now will also need another shot for the 2024-2025 fall and winter season.

David Kaslow, a representative of the Food and Drug Administration who was sworn in as a temporary voting member for the meeting, said there may be a new vaccine approved for the 2024-2025 winter season. In that case, he said, it would not be optimal for people to get a second dose of a current vaccine later than June.

The CDC already recommended in the fall that people age 5 and older get an updated vaccine to protect against serious illness. Uptake among adults has been low only about 22 percent of those 18 and older have received a dose of an updated vaccine. And only about 42 percent of those 65 and older have received a dose. People who are moderately or severely immunocompromised are already allowed to get additional doses of an updated coronavirus vaccine.

The recommendation Wednesday acknowledges that risk of severe illness continues throughout the year for older adults, not only during the winter months. Unlike flu and RSV, which usually occur in the fall and winter, coronavirus surges have occurred in the spring and summer.

This will be the third year in a row that spring boosters will be offered. Things with covid are unpredictable, CDC expert Megan Wallace told the panel. Officials are hoping the coronavirus is moving in a direction that is more like flu, with a clear season, but I dont think we are there yet, she said.

To be sure, the impact of the coronavirus has changed dramatically since the start of the pandemic in 2020, with new infections causing far fewer hospitalizations or deaths. By the end of last year, 98 percent of people in the United States had disease-fighting antibodies from vaccination or prior infection or both, for the strongest immunity.

But panel members said coronavirus infections are still at levels similar to those in years past. Another vaccine dose would restore some degree of vaccine effectiveness that may have waned since the fall.

While hospitalization rates have fallen across all age groups, certain groups continue to be hospitalized at higher rates, including older adults, infants and people with underlying medical conditions or certain disabilities. Data presented at the vaccine advisers meeting show that 67 percent of covid-19 hospitalizations from October 2023 to January 2024 were in those 65 and older. During the first seven months of 2023, adults 65 years and older accounted for 63 percent of hospitalizations and 88 percent of in-hospital deaths from covid-19, according to the CDC. There are still roughly 20,000 people a week hospitalized for covid-19 and about 2,000 deaths a week caused by the disease.

But there are drawbacks to allowing a second dose, according to data presented at the meeting. Given broad immunity in the population, there is an incremental benefit from a second dose of the updated vaccines targeting one of the omicron subvariants, XBB.1.5, that was widely circulating in the fall when the vaccines were approved by the FDA.

Allowing a second dose may decrease public confidence in the benefits of a single dose of an updated vaccine, the CDC said. Recommendations for an additional dose may also increase vaccine fatigue, potentially reducing uptake of the vaccine in the fall.

Even though the virus has continued to evolve, the CDC says the updated coronavirus vaccines continue to be effective against different circulating variants, such as JN.1, which started to dominate in January.

View original post here:

CDC vaccine advisers say older adults should get 2nd coronavirus shot - The Washington Post

Page 48«..1020..47484950..6070..»